Industry News: Volume 9, Issue 18

PRESS RELEASE: JOSEPH CARABELLO, CEO, STRATEGIC MARKETING COMMUNICATIONS, AWARDED DISTINGUISHED CONTRIBUTION AWARD AT NEW YORK HEALTH FORUM

 Hasbrouck Heights, NJ – January 2, 2018 – Joseph H. Carabello, CEO, CPR Strategic Marketing & Communications, was awarded the prestigious Distinguished Contribution Award presented by W Medical Strategy Group (WMSG) at the recently held 8th Annual New York Health Forum, Yale Club of New York.  The award recognizes and honors significant achievement by an individual or an organization that contributes to the advancement of the healthcare or beauty industry.

“Our program titled ‘Powerful Transsfor4mers of the Beauty Industry,’ provided the setting for stimulating and informative discussion on the growth trends, landscapes, risks and opportunities of today beauty industry,” says DoHyun Cho, PhD, president and CEO of W Medical Strategy Group. “The industry’s top consultants, entrepreneurs, investors, government officials, marketing experts and digital influencers came together to connect, learn and share in a diversified setting.  Sixteen panelists shared their expertise and insights with audiences, followed by the WMSG appreciation Award.”

The New York Health Forum is founded to strengthen healthcare partnerships and knowledge sharing at all levels, including industry, academia, medical and research facilities, service providers and financial investors.  Its mission is to present the significant agendas for health the healthcare industry, to contribute to public health by bringing out the public concerns to be discussed and solved, and to gather sound health policy, science innovation and industry development.

 Media Contact:

Brittany Tedesco

CPR Strategic Marketing Communications

btedesco@cpronline.com

201-641-1911 x 14

 

PRESS RELEASE: TISSUE ENGINEERING – GROWING CELLS IN THREE DIMENSIONS FOR THE ADVANCEMENT OF MEDICINE

 Cambridge, UK – Tissue engineering, broadly described as the combination of cells, engineering methods and biochemical factors to create living biological tissue, is a fast-growing field that has the potential to significantly accelerate the advancement of medicine. In IDTechEx’s new report, Tissue Engineering 2018 – 2028: Technologies, Markets, Forecasts, the market for engineered living tissues is forecasted to reach $4.8 billion by the year 2028.

The most obvious application of tissue engineering is in regenerative medicine, a branch of medicine that seeks to repair or replace damaged or diseased cells and tissues. Since the late 1990s, engineered skin grafts have been used to help accelerate the healing process for patients with advanced wounds such as diabetic foot and venous leg ulcers, and serious burns. Similarly, engineered cartilage grafts have been used for over a decade to repair defects in patients’ knees. We can imagine that in the far future, patients will be able to receive engineered organs, rather than wait for a matching organ to become available for transplant.

In the near term, researchers continue to improve the healing ability of engineered skin and cartilage, and new tissue types are also in development. These may begin to have significant impact on improving human lives within the next 5 years. Just this year the United States Food and Drug Administration has launched a program called the Regenerative Medicine Advanced Therapy designation, which was designed specifically to expediate life-changing, if not life-saving, biological products such as engineered tissues to patients. Under such a program, we may see an even more rapid commercialization of this exciting class of therapeutic than we have previously predicted.

Though the term “tissue engineering” is closely associated with regenerative medicine, the ability to artificially create living biological tissues has much wider-reaching implications than the repair of organs. By being able to replicate native structure and recapitulate function in the laboratory setting, researchers can use these engineered tissues to safety and humanely investigate the effect of drugs and other chemicals which may potentially be toxic and harmful. In reverse, tissue engineering can be used to create models of diseased tissues so that researchers can understand the underlying mechanism of the disease and to develop an appropriate therapy.

Schematic depicting the drug development process. Use of engineered tissues in preclinical testing can help catch safety issues earlier on to avoid costly clinical trial and market failures. Source: IDTechEx.

Using engineered tissues, pharmaceutical companies can expect to accelerate their drug development timelines and to potentially save billions of dollars in the process. Tests on engineered human tissues have the potential to replace traditional cell culture and animal studies, both of which often provide unreliable results due to dissimilarity to human physiology. By predicting the safety and efficacy of the drug in preclinical studies, resources can be focused to pursue the most promising therapeutics, and dead-ends can be identified and discarded before significant money has been invested.

IDTechEx’s report, Tissue Engineering 2018 – 2028: Technologies, Markets, Forecasts, covers the above applications for engineered tissues, associated business models, markets, and forecasts to 2028. The report is complemented by a discussion of the wide range of techniques and technologies that can be used to fabricate living biological structures. These techniques can be as simple as mixing cells in a polymer solution and allowing the mixture to set into a 3D structure, or they can be as complex as the controlled deposition of cells by a 3D bioprinter.

For more information about the exciting opportunities for tissue engineering, please see www.idtechex.com/tissue.

About IDTechEx

IDTechEx guides your strategic business decisions through its Research and Events services, helping you profit from emerging technologies. We provide independent research, business intelligence and advice to companies across the value chain based on research activities and methodologies which provide data sought by business leaders, strategists and technology scouts to aid their critical business decisions. To discuss your needs please contact us at research@IDTechEx.com or see www.IDTechEx.com.

Contact:

Charlotte Hibbert

Marketing & Research Co-ordinator

c.hibbert@IDTechEx.com

UK: +44-(0)1223-810286

 

How the Growing LEP Patient Population is Increasing the Need for Remote Interpreting

By David Fetterolf

 As a result of the ebb and flow of immigration, the most widely spoken languages in the United States have changed drastically in the last twenty years. Although the United States has always been known for its linguistic diversity, due in part to our “melting pot” mentality, census records show these changes are much more striking than in the past.

The steady increase in language diversity – and alternation of the most popular languages – has greatly impacted the demand for language access services in healthcare and beyond. Previously established language access plans have become obsolete due to a decrease in the use of some languages and a rapid increase in others. In addition, refugee resettlements and population concentrations of specific languages have contributed to this nationwide need for redefined language access solutions.

Language Patterns in the U.S.

 Certain areas of the country tend to harbor specific language groups. These population concentrations are the result of chain migration influenced by points of entry into the United States and family connections. Over time, internal migration trends, employment opportunities and other family factors dictate language group hubs within the country.

In 2010, nine percent of the US population over age five was comprised of individuals with Limited English Proficiency (LEP). LEP individuals were primarily found in six states, traditionally known as the immigrant destination states: California, Texas, New York, Florida, Illinois and New Jersey. Each of these states had 1 million or more residents who spoke a language other than English at home and together harbored 68 percent of the total LEP population in the United States.

Although the majority of LEP residents were found living in the immigrant destination states, other states had high shares of LEP residents when compared to their total populations. In 13 states, the share of the LEP population in comparison to the total state population was equal to or more than the national average, including California, Texas, New York, New Jersey, Nevada, Florida, Hawaii, Arizona, Illinois, Rhode Island, New Mexico, Massachusetts and Connecticut.

These internal migration trends demonstrate a steady influx of individuals who speak a language other than English into states that have not traditionally harbored high percentages of LEP persons. As a result, many of these states are faced with the daunting task of providing language access services for a rapidly growing population that greatly exceeds their current resources.

Diverse Language Needs in Healthcare

 This is particularly evident in the realm of healthcare. Any facility receiving federal funds is mandated by Section 1557 of the Affordable Care Act (ACA) to provide qualified language services to LEP and Deaf/HoH patients at no charge. The mandate expressly prohibits the use of ad hoc interpreters, including family members, friends and untrained bilingual staff, barring extreme circumstances.

In addition, healthcare facilities are encountering less common languages on a regular basis. This shakes up traditional language access programs and, in many cases, calls for a new approach to providing medical interpretation. As a result, health care organizations are in search of more robust interpreting solutions that can adequately facilitate communication with an increasingly diverse patient population.

Remote Interpreting Expands Language Access in Healthcare 

The use of both over-the-phone and video remote interpreting greatly expands language access in healthcare, providing non-English speaking patients with access to hospital interpreters qualified in a wide range of languages. In addition to greatly widening the scope of languages provided, the immediate, on-demand nature of remote interpreting eliminates both scheduling and travel time, resulting in faster access for the patient and reduced cost for the healthcare facility.

The two technologies each come with their own list of advantages and use-cases:

  • Video remote interpretation (VRI):
    • Combines the benefits of face-to-face interpretation with the on-demand nature of over-the-phone interpretation (OPI).
    • Is instant, mobile, and cost effective.
    • Patients are able to see and hear a qualified medical interpreter in their language with just the push of a button.
    • Interpreters are trained to pick up on nonverbal cues essential in ensuring meaningful communication is taking place.
    • Is often preferred for conversations of immediate need, as interpreters can be reached very quickly – typically in 30 seconds or less.
  • Over-the-phone interpretation:
    • Is easy to install and integrate into existing language access plans. Providers simply pick up the phone and dial a dedicated number to reach a telephonic interpretation service that provides qualified interpretation in a wide range of languages.
    • Interpreters are experts in consecutive interpreting, meaning they have the skill set to listen to the patient and provider, process and then convey the message into the target language without delay.
    • Is preferred for conversations that do not require visual cues, such as appointment settings and follow-ups.

With the significant increase of frequently encountered languages in healthcare, hospitals, health systems and other healthcare facilities are incorporating remote interpreting into existing language access plans. Remote interpreting enables hospitals to not only better serve their non-English patient population but also adhere to federal mandates that require the provision of language services.

About David Fetterolf

David leads the overall strategic direction of Stratus Video’s Language Services division. David brings over 26 years of experience working for healthcare information technology and service companies. Prior to joining Stratus Video, he was president and founder of MDeverywhere, revenue cycle management software tailored to the healthcare industry. In 2011 MDeverywhere made the coveted Inc. 500/5000 fastest growing companies list. Prior to MDeverywhere, David was a division president for Datamedic, a leading provider of computer-based patient records and business management software and services for medical practices and clinics. As division president, he was responsible for strategy and financial performance, which included leading the marketing, sales, implementation, support, and manufacturing and development teams. David has a Bachelor’s degree in Electrical Engineering from Cornell University and a Masters of Business Administration from The Wharton School at the University of Pennsylvania.

 

Moody’s: 2018 global healthcare outlook stable as demand for services continues to rise

By Paige Minemyer

Fiercehealthcare.com – The financial outlook for the healthcare industry worldwide in 2018 is stable, according to Moody’s Investors Service.

Moody’s predicts that, in many countries, healthcare will represent a rising portion of their gross domestic product (GDP), which offers plenty of chances for healthcare companies to grow. However, it could tighten governments’ purse strings.

Michael Levesque, a senior vice president for Moody’s, said that as demand for healthcare increases, payers are likely to focus on initiatives that improve cost-effectiveness. Legislators can support this by allowing for greater price flexibility or reducing demand, but Moody’s projects that insurers will continue to have patients shoulder more of the cost burden.

To view the original article, click here.

 

Thermal Medicine experts establish World Academy of Chinese and Complementary Medicine  

 tornosnews.gr – The establishment of the World Academy of Chinese and Complementary Medicine was announced during the 3rd Panhellenic Conference of the Hellenic Thermal Medicine Academy with founding members distinguished doctors and dentists of global reach and expertise.

Its aim is to further investigate the effectiveness of several already approved complementary methods (acupuncture, ozonotherapy) as well as other methods, always in cooperation with traditional classic Western medicine, which is unified and dominant.

Last weekend, experts and local authorities met for the 3rd Panhellenic Conference of the Thermal Medicine Academy to discuss ways to tap into the more than 700 thermal springs across Greece in order to promote wellness tourism and attract travelers to Greek destinations all year round.

The Hellenic Academy of Thermal Medicine, founded in 2015, is a voluntary health organization based in Athens and dedicated to the development of thermal culture in Greece among professionals of medicine and consumers. It intends to be a recognized seat for study and research of natural factors (spring mineral water, mud, seaweed, seawater, climate etc). Its President is Professor of Dermatology Konstantinos Kouskoukis from the Democritus University of Thrace, Greece.

A key goal of the Academy is to establish a research or scientific collaboration with medical and technical associations interested in Thermal Medicine and related activities, in order to strengthen and enhance the action mechanisms, the therapeutic efficiency of thermal treatments for the immediate benefit of patients. In general, to carry out any other actions that would be beneficial for the evolution of Thermal Medicine.

To view the original article, click here.

Leave a Reply

Top